GB8624213D0 - Sustained release pharmaceutical compositions - Google Patents

Sustained release pharmaceutical compositions

Info

Publication number
GB8624213D0
GB8624213D0 GB868624213A GB8624213A GB8624213D0 GB 8624213 D0 GB8624213 D0 GB 8624213D0 GB 868624213 A GB868624213 A GB 868624213A GB 8624213 A GB8624213 A GB 8624213A GB 8624213 D0 GB8624213 D0 GB 8624213D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
sustained release
release pharmaceutical
sustained
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB868624213A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz Canada Inc
Original Assignee
Sandoz Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Canada Inc filed Critical Sandoz Canada Inc
Priority to GB868624213A priority Critical patent/GB8624213D0/en
Publication of GB8624213D0 publication Critical patent/GB8624213D0/en
Priority to NL8702294A priority patent/NL8702294A/en
Priority to HU874311A priority patent/HU201875B/en
Priority to BE8701131A priority patent/BE1000732A5/en
Priority to CH3838/87A priority patent/CH675831A5/de
Priority to FR878713759A priority patent/FR2604902B1/en
Priority to DE19873733540 priority patent/DE3733540A1/en
Priority to LU87009A priority patent/LU87009A1/en
Priority to IL84104A priority patent/IL84104A0/en
Priority to KR870011168A priority patent/KR880004801A/en
Priority to NZ222083A priority patent/NZ222083A/en
Priority to GR871550A priority patent/GR871550B/en
Priority to NO874200A priority patent/NO874200L/en
Priority to GB8723515A priority patent/GB2195893B/en
Priority to AU79420/87A priority patent/AU7942087A/en
Priority to PT85880A priority patent/PT85880B/en
Priority to FI874414A priority patent/FI874414A/en
Priority to IT48469/87A priority patent/IT1221493B/en
Priority to JP62256149A priority patent/JPS63101334A/en
Priority to ES8702873A priority patent/ES2014518A6/en
Priority to PH35906A priority patent/PH24227A/en
Priority to SE8703889A priority patent/SE8703889L/en
Priority to CA000548872A priority patent/CA1332809C/en
Priority to DK527487A priority patent/DK527487A/en
Priority to ZA877617A priority patent/ZA877617B/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
GB868624213A 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions Pending GB8624213D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions
NL8702294A NL8702294A (en) 1986-10-09 1987-09-25 PHARMACEUTICAL PREPARATIONS WITH SUSTAINABLE DELIVERY.
HU874311A HU201875B (en) 1986-10-09 1987-09-25 Process for producing retarde pharmaceutical compositions containing acetyl-salicylic acid
BE8701131A BE1000732A5 (en) 1986-10-09 1987-10-02 Pharmaceutical Compositions A SUSTAINED RELEASE.
CH3838/87A CH675831A5 (en) 1986-10-09 1987-10-02
FR878713759A FR2604902B1 (en) 1986-10-09 1987-10-02 SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS
DE19873733540 DE3733540A1 (en) 1986-10-09 1987-10-03 A PHARMACEUTICAL COMPOSITION WITH DELAYED RELEASE OF THE ACTIVE SUBSTANCE
LU87009A LU87009A1 (en) 1986-10-09 1987-10-06 SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS
IL84104A IL84104A0 (en) 1986-10-09 1987-10-06 Sustained release pharmaceutical compositions and their preparation
KR870011168A KR880004801A (en) 1986-10-09 1987-10-06 Sustained-release pharmaceutical composition
FI874414A FI874414A (en) 1986-10-09 1987-10-07 CONTROLLED PHARMACEUTICAL COMPOSITION.
NO874200A NO874200L (en) 1986-10-09 1987-10-07 PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
GR871550A GR871550B (en) 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions
NZ222083A NZ222083A (en) 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose
GB8723515A GB2195893B (en) 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions
AU79420/87A AU7942087A (en) 1986-10-09 1987-10-07 Sustained release formulations
PT85880A PT85880B (en) 1986-10-09 1987-10-07 BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for the preparation of delayed-acting pharmaceutical compositions comprising as carrier substance a mixture of microcrystalline cellulose with hydroxypropyl methylcellulose
DK527487A DK527487A (en) 1986-10-09 1987-10-08 PHARMACEUTICAL PREPARATIONS WITH EXTENDED DELIVERY
IT48469/87A IT1221493B (en) 1986-10-09 1987-10-08 DELAYED PHARMACEUTICAL COMPOSITIONS
JP62256149A JPS63101334A (en) 1986-10-09 1987-10-08 Long release medicinal composition
ES8702873A ES2014518A6 (en) 1986-10-09 1987-10-08 Sustained release composition
PH35906A PH24227A (en) 1986-10-09 1987-10-08 Sustained released pharmaceutical compositions
SE8703889A SE8703889L (en) 1986-10-09 1987-10-08 PHARMACEUTICAL COMPOSITIONS WITH DELAYED RELEASE
CA000548872A CA1332809C (en) 1986-10-09 1987-10-08 Sustained release pharmaceutical compositions
ZA877617A ZA877617B (en) 1986-10-09 1987-10-09 Sustained release pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB8624213D0 true GB8624213D0 (en) 1986-11-12

Family

ID=10605478

Family Applications (2)

Application Number Title Priority Date Filing Date
GB868624213A Pending GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions
GB8723515A Expired - Lifetime GB2195893B (en) 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8723515A Expired - Lifetime GB2195893B (en) 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions

Country Status (24)

Country Link
JP (1) JPS63101334A (en)
KR (1) KR880004801A (en)
AU (1) AU7942087A (en)
BE (1) BE1000732A5 (en)
CA (1) CA1332809C (en)
CH (1) CH675831A5 (en)
DE (1) DE3733540A1 (en)
DK (1) DK527487A (en)
ES (1) ES2014518A6 (en)
FI (1) FI874414A (en)
FR (1) FR2604902B1 (en)
GB (2) GB8624213D0 (en)
GR (1) GR871550B (en)
HU (1) HU201875B (en)
IL (1) IL84104A0 (en)
IT (1) IT1221493B (en)
LU (1) LU87009A1 (en)
NL (1) NL8702294A (en)
NO (1) NO874200L (en)
NZ (1) NZ222083A (en)
PH (1) PH24227A (en)
PT (1) PT85880B (en)
SE (1) SE8703889L (en)
ZA (1) ZA877617B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
KR20100036398A (en) * 1999-03-31 2010-04-07 얀센 파마슈티카 엔.브이. Pregelatinized starch in a controlled release formulation
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102887D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
DE602004022205D1 (en) * 2004-09-09 2009-09-03 Psicofarma S A De C V PHARMACEUTICAL COMPOSITION FOR THE DELAYED RELEASE OF HYDRALAZINE AND ITS USE AS A SUPPORT FOR CANCER THERAPY

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (en) * 1972-02-22 1973-08-22 Lilly Co Eli PROPOXYPHENE DELAY NAPSYLATE PARTICLES AND PROCESS FOR MANUFACTURING SUCH PARTICLES
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (en) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen ORAL RETARDED ACETYLSALICYL ACID FORMULATIONS
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
BE1000732A5 (en) 1989-03-21
JPS63101334A (en) 1988-05-06
DK527487A (en) 1988-04-10
IT8748469A0 (en) 1987-10-08
GR871550B (en) 1988-02-15
KR880004801A (en) 1988-06-27
HUT52958A (en) 1990-09-28
IT1221493B (en) 1990-07-06
GB8723515D0 (en) 1987-11-11
ZA877617B (en) 1989-05-30
PT85880A (en) 1987-11-01
PT85880B (en) 1990-07-31
CH675831A5 (en) 1990-11-15
AU7942087A (en) 1988-04-14
SE8703889D0 (en) 1987-10-08
CA1332809C (en) 1994-11-01
NL8702294A (en) 1988-05-02
FI874414A (en) 1988-04-10
PH24227A (en) 1990-05-04
FR2604902B1 (en) 1991-04-26
NO874200D0 (en) 1987-10-07
FR2604902A1 (en) 1988-04-15
GB2195893B (en) 1991-05-08
IL84104A0 (en) 1988-03-31
HU201875B (en) 1991-01-28
DK527487D0 (en) 1987-10-08
NO874200L (en) 1988-04-11
NZ222083A (en) 1991-05-28
DE3733540A1 (en) 1988-04-14
GB2195893A (en) 1988-04-20
SE8703889L (en) 1988-04-10
LU87009A1 (en) 1988-05-03
FI874414A0 (en) 1987-10-07
ES2014518A6 (en) 1990-07-16

Similar Documents

Publication Publication Date Title
GB2230185B (en) Sustained release pharmaceutical compositions
GB2196964B (en) Pharmaceutical compositions
AR243378A1 (en) Sustained release pharmaceutical composition
GB8716301D0 (en) Pharmaceutical compositions
GB8717582D0 (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
GB8608818D0 (en) Pharmaceutical compositions
GB8717581D0 (en) Pharmaceutical compositions
IL82924A0 (en) Sustained release pharmaceutical compositions containing katotifen
GB8618259D0 (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
GB8629781D0 (en) Pharmaceutical compositions
ZA904925B (en) Sustained release pharmaceutical compositions
GB2195893B (en) Sustained release pharmaceutical compositions
GB8723118D0 (en) Pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
GB8620073D0 (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
GB8713566D0 (en) Pharmaceutical compositions
GB8624214D0 (en) Sustained release pharmaceutical compositions
GB8413797D0 (en) Sustained release pharmaceutical compositions
GB8413796D0 (en) Sustained release pharmaceutical compositions
GB8612806D0 (en) Pharmaceutical compositions
GB8626216D0 (en) Pharmaceutical compositions
GB8626217D0 (en) Pharmaceutical compositions